197 related items for PubMed ID: 23744100
1. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
Kim SY, Han MY, Cha SH, Jeon YB.
Pediatr Cardiol; 2013; 34(8):1837-43. PubMed ID: 23744100
[Abstract] [Full Text] [Related]
2. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
Pediatr Rheumatol Online J; 2019 Sep 18; 17(1):65. PubMed ID: 31533770
[Abstract] [Full Text] [Related]
3. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
4. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
Clin Drug Investig; 2011 Mar 21; 31(3):191-9. PubMed ID: 21456105
[Abstract] [Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
J Pediatr; 2013 Jun 21; 162(6):1205-9. PubMed ID: 23290510
[Abstract] [Full Text] [Related]
6. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
Arthritis Rheumatol; 2015 Jul 21; 67(7):1943-50. PubMed ID: 25778686
[Abstract] [Full Text] [Related]
7. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
Front Immunol; 2021 Jul 21; 12():624802. PubMed ID: 33912155
[Abstract] [Full Text] [Related]
8. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.
Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, Spiegelblatt L, Bonny Y, Vartian M, Montigny M.
Pediatr Cardiol; 2009 Aug 21; 30(6):810-7. PubMed ID: 19365652
[Abstract] [Full Text] [Related]
9. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.
Kaneko K, Yoshimura K, Ohashi A, Kimata T, Shimo T, Tsuji S.
Pediatr Cardiol; 2011 Dec 21; 32(8):1106-9. PubMed ID: 21487793
[Abstract] [Full Text] [Related]
10. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar 21; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
11. A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.
Joung J, Oh JS, Yoon JM, Ko KO, Yoo GH, Cheon EJ.
BMC Pediatr; 2022 Aug 05; 22(1):474. PubMed ID: 35931986
[Abstract] [Full Text] [Related]
12. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A, Pal P, Basu S.
Rheumatol Int; 2019 Oct 05; 39(10):1797-1801. PubMed ID: 31302740
[Abstract] [Full Text] [Related]
13. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
Kwon H, Lee JH, Jung JY, Kwak YH, Kim DK, Jung JH, Chang I, Kim K.
Eur J Pediatr; 2016 Dec 05; 175(12):1997-2003. PubMed ID: 27798729
[Abstract] [Full Text] [Related]
14. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK.
Rheumatol Int; 2016 Apr 05; 36(4):551-9. PubMed ID: 26849890
[Abstract] [Full Text] [Related]
15. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
Acta Paediatr; 2010 Oct 05; 99(10):1578-83. PubMed ID: 20491705
[Abstract] [Full Text] [Related]
16. B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.
Iwashima S, Ishikawa T.
World J Pediatr; 2013 Aug 05; 9(3):239-44. PubMed ID: 23335186
[Abstract] [Full Text] [Related]
17. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease.
Yanagisawa D, Ayusawa M, Kato M, Watanabe H, Komori A, Abe Y, Nakamura T, Kamiyama H, Takahashi S.
Pediatr Int; 2016 Nov 05; 58(11):1105-1111. PubMed ID: 26991905
[Abstract] [Full Text] [Related]
18. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L, Yaping L, Xiufen H.
Zhonghua Er Ke Za Zhi; 2015 Apr 05; 53(4):300-3. PubMed ID: 26182507
[Abstract] [Full Text] [Related]
19. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
[Abstract] [Full Text] [Related]
20. Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease.
Lee HY, Song MS.
Korean J Pediatr; 2016 Dec 27; 59(12):477-482. PubMed ID: 28194213
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
